A ASTRIA
Live / Allowed — Notice of allowance issued (as of 13 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Jun 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98581433
- Mark type
- Design + words
- Filed
- 03 Jun 2024
- Published for opposition
- 18 Nov 2025
- Attorney of record
- Richard Todd Armstrong, Ph.D.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of allergic and inflammatory diseases and disorders; all of the foregoing do not contain cannabis, hemp, or derivatives thereof
Owner
- Astria Therapeutics, Inc., Boston, MA, US
- Astria Therapeutics, Inc., Boston, MA, US
Prosecution history
- 13 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Dec 2025 — POST PUBLICATION AMENDMENT - ENTERED
- 11 Dec 2025 — ASSIGNED TO PETITION STAFF
- 18 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Nov 2025 — PUBLISHED FOR OPPOSITION
- 12 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Oct 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 16 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Jun 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 17 Dec 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 17 Dec 2024 — LETTER OF SUSPENSION E-MAILED
- 17 Dec 2024 — SUSPENSION LETTER WRITTEN
- 16 Dec 2024 — ASSIGNED TO EXAMINER
- 15 Dec 2024 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 15 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED